Perturbation-Driven Entropy as a Source of Cancer Cell Heterogeneity

Trends Cancer. 2020 Jun;6(6):454-461. doi: 10.1016/j.trecan.2020.02.016. Epub 2020 Mar 13.

Abstract

Intratumor heterogeneity is a key hallmark of cancer that contributes to progression and therapeutic resistance. Phenotypic heterogeneity is in part caused by Darwinian selection of subclones that arise by random (epi)genetic aberrations. In addition, cancer cells are endowed with increased cellular plasticity compared with their normal counterparts, further adding to their heterogeneous behavior. However, the molecular mechanisms underpinning cancer cell plasticity are incompletely understood. Here, I outline the hypothesis that cancer-associated perturbations collectively disrupt normal gene regulatory networks (GRNs) by increasing their entropy. Importantly, in this model both somatic driver and passenger alterations contribute to 'perturbation-driven entropy', thereby increasing phenotypic heterogeneity and evolvability. This additional layer of heterogeneity may contribute to our understanding of cancer evolution and therapeutic resistance.

Keywords: cancer heterogeneity; entropy; gene regulatory networks; therapeutic resistance.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Cell Plasticity / genetics
  • Drug Resistance, Neoplasm / genetics
  • Entropy
  • Epigenesis, Genetic
  • Evolution, Molecular*
  • Gene Expression Regulation, Neoplastic*
  • Gene Regulatory Networks*
  • Genetic Heterogeneity*
  • Humans
  • Models, Genetic
  • Mutation
  • Neoplasms / drug therapy
  • Neoplasms / genetics*
  • Neoplasms / pathology
  • Neoplastic Stem Cells / pathology

Substances

  • Antineoplastic Agents